Walleye Capital LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$492,871
+64.8%
8,489
-8.1%
0.00%
-98.5%
Q2 2020$299,0000.0%9,235
+90.8%
0.07%
+235.0%
Q4 2019$299,000
-79.3%
4,839
-75.6%
0.02%
-76.5%
Q3 2019$1,443,000
-28.0%
19,802
-18.7%
0.08%
-61.4%
Q2 2019$2,003,000
-24.1%
24,356
-34.9%
0.22%
-49.3%
Q1 2019$2,640,00037,4200.43%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders